HomeCompareGTXO vs MRK

GTXO vs MRK: Dividend Comparison 2026

GTXO yields 40000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GTXO wins by $5.18024517379999e+22M in total portfolio value
10 years
GTXO
GTXO
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.18024517379999e+22M
Annual income
$51,548,940,318,215,365,000,000,000,000.00
Full GTXO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GTXO vs MRK

📍 GTXO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGTXOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GTXO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GTXO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GTXO
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$43,816,599,270,483,060,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GTXO beats the other by $43,816,599,270,483,060,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GTXO + MRK for your $10,000?

GTXO: 50%MRK: 50%
100% MRK50/50100% GTXO
Portfolio after 10yr
$2.590122586899995e+22M
Annual income
$25,774,470,159,107,683,000,000,000,000.00/yr
Blended yield
99.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GTXO
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GTXO buys
0
MRK buys
0
No recent congressional trades found for GTXO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGTXOMRK
Forward yield40000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.18024517379999e+22M$56.8K
Annual income after 10y$51,548,940,318,215,365,000,000,000,000.00$9,798.13
Total dividends collected$5.178579568047658e+22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GTXO vs MRK ($10,000, DRIP)

YearGTXO PortfolioGTXO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$4,010,700$4,000,000.00$11,206$366.19+$4.00MGTXO
2$1,503,618,552$1,499,327,102.80$12,650$502.35+$1503.61MGTXO
3$526,936,342,129$525,327,470,278.19$14,407$694.19+$526936.33MGTXO
4$172,618,628,820,566$172,054,806,934,488.28$16,585$967.82+$172618628.80MGTXO
5$52,860,672,107,805,460$52,675,970,174,967,450.00$19,342$1,363.89+$52860672107.79MGTXO
6$15,132,132,379,588,594,000$15,075,571,460,433,242,000.00$22,913$1,947.19+$15132132379588.57MGTXO
7$4,049,462,878,006,525,600,000$4,033,271,496,360,366,000,000.00$27,662$2,823.89+$4049462878006525.50MGTXO
8$1,013,053,710,099,385,500,000,000$1,008,720,784,819,918,400,000,000.00$34,159$4,173.35+$1013053710099385472.00MGTXO
9$236,926,560,546,299,530,000,000,000$235,842,593,076,493,200,000,000,000.00$43,337$6,308.80+$236926560546299510784.00MGTXO
10$51,802,451,737,999,890,000,000,000,000$51,548,940,318,215,365,000,000,000,000.00$56,776$9,798.13+$5.18024517379999e+22MGTXO

GTXO vs MRK: Complete Analysis 2026

GTXOStock

GTX Corp. designs, develops, manufactures, and sells various products and services in the personal location services marketplace in the United States and internationally. The company offers global positioning system (GPS), Bluetooth low energy (BLE), and cellular location platform that enables subscribers to track in real time the whereabouts of people, pets, or high valued assets through a miniaturized transceiver module, wireless connectivity gateway, middleware, and viewing portal. Its products include GPS SmartSole, a wearable orthotic insole GPS tracking, monitoring, and recovery solution for those at risk of wandering due to Alzheimer's, dementia, and autism; Take Along Tracker 4G, a miniature tracking and SOS device; Sole Protector for GPS Smartsole; Take Along Friends & the Invisabelt, a GPS cellular tracking and monitoring device for young children and toddlers; Protective Medical devices and supplies, such as masks, sanitizers, face shields, UV wands, and various equipment, as well as antibody and antigen rapid test kits and hearing assisted technologies; and VeriTap, an near field communications (NFC) tag and middleware application to monitor logistics and assets in the supply chain. The company also develops and owns LOCiMOBILE, a suite of mobile tracking applications that turn smartphones and tablets, such as iPhone, iPad, Google Android, and other GPS enabled handsets into a tracking and location based real-time tracking device, which can be viewed through its tracking portal or on any connected device with internet access. In addition, it offers Track My Work Force, which allows employers to track and monitor employees, drivers, sales representatives, and others using their smartphones, tablets, or other wireless devices; and other applications. The company serves the consumer, enterprise, and military markets. GTX Corp. has collaboration with TulsaLabs. GTX Corp was founded in 2002 and is headquartered in Los Angeles, California.

Full GTXO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GTXO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GTXO vs SCHDGTXO vs JEPIGTXO vs OGTXO vs KOGTXO vs MAINGTXO vs JNJGTXO vs ABBVGTXO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.